Related references
Note: Only part of the references are listed.Clinical Staging Uncertainty and Treatment Sequencing in Pancreatic Cancer
Filip Bednar
ANNALS OF SURGERY (2022)
Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma
Wilson Luiz da costa et al.
ANNALS OF SURGERY (2022)
Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9
Seung-Seob Kim et al.
RADIOLOGY (2022)
Advances and Remaining Challenges in the Treatment for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Megan L. Sulciner et al.
JOURNAL OF CLINICAL MEDICINE (2022)
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy
Jong Keon Jang et al.
EUROPEAN RADIOLOGY (2021)
Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study
Felipe S. Furtado et al.
MOLECULAR IMAGING AND BIOLOGY (2021)
Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival
Ananya Panda et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2021)
The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review
Laura Evangelista et al.
ANNALS OF NUCLEAR MEDICINE (2021)
Pancreatic Cancer: A Review
Wungki Park et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma
Hyungjin Rhee et al.
KOREAN JOURNAL OF RADIOLOGY (2021)
Difference between carbohydrate antigen 19-9 and fluorine-18 fluorodeoxyglucose positron emission tomography in evaluating the treatment efficacy of neoadjuvant treatment in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma: Results of a dual-center study
Hirofumi Akita et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)
CT in the prediction of margin-negative resection in pancreatic cancer following neoadjuvant treatment: a systematic review and meta-analysis
Sohee Park et al.
EUROPEAN RADIOLOGY (2021)
Induction chemotherapy in pancreatic cancer: CA 19-9 may predict resectability and survival
Ulrike Heger et al.
HPB (2020)
Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer
Susan Tsai et al.
ANNALS OF SURGERY (2020)
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease
Naveen M. Kulkarni et al.
ABDOMINAL RADIOLOGY (2020)
Diffusion-weighted MRI predicts the histologic response for neoadjuvant therapy in patients with pancreatic cancer: a prospective study (DIFFERENT trial)
Ken-ichi Okada et al.
LANGENBECKS ARCHIVES OF SURGERY (2020)
Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer
Cosimo Sperti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Imaging response evaluation after novel neoadjuvant treatments of pancreatic cancer
Eva-Maria Gassner et al.
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA (2019)
Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy
Ijin Joo et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
PET/MR Imaging of the Pancreas
Nadine Mallak et al.
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA (2018)
Pancreatic Adenocarcinoma Staging in the Era of Preoperative Chemotherapy and Radiation Therapy
Marc Zins et al.
RADIOLOGY (2018)
Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy
Eran van Veldhuisen et al.
HPB (2018)
Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy
Eric A. Mellon et al.
ACTA ONCOLOGICA (2017)
Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study
Ijin Joo et al.
RADIOLOGY (2017)
Has survival improved following resection for pancreatic adenocarcinoma?
Kenneth Luberice et al.
AMERICAN JOURNAL OF SURGERY (2017)
Added Value of Integrated Whole-Body PET/MRI for Evaluation of Colorectal Cancer: Comparison With Contrast-Enhanced MDCT
Beomsik Kang et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging
Dong Ho Lee et al.
RADIOLOGY (2016)
Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer
Wei-Ching Lin et al.
TRANSLATIONAL ONCOLOGY (2015)
Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection
Hua-Xiang Xu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer
Jeong Won Lee et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment
Christophe Cassinotto et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Staging of pancreatic cancer before and after neoadjuvant chemoradiation
RR White et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2001)
Share Paper
